Progyny, Inc.
About Progyny, Inc.
Progyny, Inc. is a benefits management company specializing in fertility, family building, and women’s health benefits solutions, working primarily with employers, health plans, and benefit purchasers. Its offerings combine benefit design, clinical networks, pharmacy-related services, concierge support, and digital tools, with an expanding focus that now includes pregnancy, postpartum, and menopause programs. The company emphasizes research, advocacy, and recognition in women’s health and supports its operations with a Nasdaq-listed equity structure.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $67.4M total across three rounds ending with Series B in 2017.
- Filed S-1 for IPO in 2019 with lead underwriters J.P. Morgan, Goldman Sachs and Bank of America Merrill Lynch.
- Reports in-network IVF pregnancy rates of 60.7% versus 52.5% across all IVF clinics.
- Operates with a revolving credit facility for financial flexibility as a NASDAQ-listed entity.
- Employs 846 people and focuses on employer-sponsored fertility and women’s health benefits.
Ask StreetZero about Progyny, Inc.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account